Most Popular in:


Email This Item! Print This Item!

New Patch Treats Skin Cancer

Posted: June 18, 2009

page 2 of 2

Three months after treatment, biopsies of all of the patients' skin cancer sites revealed no residual malignant cancer. The treatment had few adverse effects and resulted in minimal scarring. In addition, routine blood and biochemical exams did not reveal any toxicity from the radioactive patches. Phosporous-32 poses no external radiation hazards, and its limited range prevents beta radiation from reaching the bone or underlying blood vessels, thus sparing the bone and bone marrow.

Scientific Paper 158: P. Gupta, A. Malhotra, S. Saxena, S. Gupta, G.P. Bandhopadhyaya, M. Venkatesh, U. Pandey, Department of Nuclear Medicine and Department of Dermatology, All India Institute of Medical Sciences (AIIMS), New Delhi; and Board of Radiation and Isotope Therapy (BRIT) Bhabha Atomic Research Center (BARC), Mumbai; "Radionuclide therapy of basal cell carcinoma with Phosphorus-32 skin patch," SNM's 56th Annual Meeting, June 13–17, 2009.

Adapted from materials provided by Society of Nuclear Medicine.

ScienceDaily, June 15, 2009